Delivery Order SPE2DB20D3101-SPE2DB25FRCU0

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,335.54, is for the delivery of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a medical product, with a completion date of December 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The contract has a firm fixed price of $3,640.66 and a completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $1,664.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566681918 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566945457 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,331.60 and an ultimate completion date of January 16, 2025. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $2,702.50, is for the supply of 4565024978 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a critical medical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,443.54, is for the delivery of 4566376667 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialized pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $4,567.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of 4566649350 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, with a completion date of December 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FRDB6, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of 4567409299 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The award has a ceiling value of $7,225.89 and is a Firm Fixed Price Delivery Order contract, with a period of performance through February 28, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,931.20 firm fixed-price contract is for the supply of various pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, valued at $2,759.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRCU0
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,517.37, is for the delivery of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:16 AM